Breezula (aka "CB-13-01," aka "cortexolone-17α-propionate" 5% topical lotion) is on track for an expected launch in 2021. Hold fast! The product is currently entering Phase II Dose Range trials in 2017. You can track the progress at the manufacturer, Cassiopea's, website...